OverviewChartNewsTraderScreen

L&S Knock-Out MDGD/  DE000LX3ND92  /

Lang & Schwarz
05/06/2024  17:43:39 Chg.+0.009 Bid17:43:39 Ask17:43:39 Underlying Strike price Expiration date Option type
0.061EUR +17.31% 0.061
Bid Size: -		 0.077
Ask Size: -		 MEDIGENE AG NA O.N. 0.7987 EUR 31/12/2078 Call
GlobeNewswire 28/05 Medigene AG Expands its End-to-End Platform by Submitting Three Development Optimization Technology ...
GlobeNewswire 21/05 Medigene's Global Research & Collaboration Agreement with BioNTech to Extend Beyond Initially Announ...
GlobeNewswire 15/05 Medigene Presents Preclinical Data on Optimal Affinity TCRs Targeting the Neoantigen Mutant KRAS
GlobeNewswire 14/05 Medigene AG Extends Cash Runway into July 2025 After Successful Oversubscribed Capital Raise
GlobeNewswire 07/05 Medigene to Present at Upcoming Conferences
GlobeNewswire 06/05 The Benchmark Company Announces Upcoming Healthcare House Call VIRTUAL One-on-One Investor Conferenc...
GlobeNewswire 02/05 Medigene AG Expands Patent Portfolio with European Patent Grant for its NY-ESO-1 – targeted T Cell R...
GlobeNewswire 02/05 Medigene Presents Superior TCR-T Cell Functionality by Inclusion of a Costimulatory Switch Protein
GlobeNewswire 26/04 Medigene AG reports Financial Results and Business Update for Q1 2024
GlobeNewswire 25/04 Medigene presents streamlined 6-day, high stemness TCR-T therapy production process
GlobeNewswire 17/04 Medigene to Present at Upcoming Scientific Conferences
GlobeNewswire 08/04 Medigene Presents Favorable Safety Profile of TCR-T Cells with Costimulatory Switch Protein at AACR ...
GlobeNewswire 04/04 Medigene AG Secures European Patent for its iM-TCR Technology
GlobeNewswire 28/03 Medigene AG Reports Full-Year 2023 Financial Results and Provides Corporate Update
GlobeNewswire 19/03 Medigene AG to participate in the H.C. Wainwright 2nd Annual Cell Therapy Virtual Conference
GlobeNewswire 18/03 Medigene AG to report full year 2023 financial results on March 28, 2024
GlobeNewswire 06/03 Medigene to Present Favorable Safety Profile of TCR-T Cells upon Addition of Costimulatory Switch Pr...
GlobeNewswire 04/03 Medigene AG Expands Patent Portfolio in Japan for iM-TCR Technology to Directly Control TCR-T Safety...
GlobeNewswire 29/02 Medigene Presents at CAR-TCR Summit Europe Showcasing Unique Approach for Development of Differentia...
GlobeNewswire 19/02 Medigene to Present at Upcoming Conferences
GlobeNewswire 12/02 Medigene Announces Indication Selection for the Clinical Development of its Lead 3rd Generation TCR...
GlobeNewswire 19/12/2023 Medigene AG to attend at the 42nd Annual J.P. Morgan Healthcare Conference
GlobeNewswire 21/11/2023 Medigene AG Announces Prioritization of Pipeline and Resource Allocation as well as Extension of Cas...
GlobeNewswire 21/11/2023 Medigene amends 2023 financial guidance
GlobeNewswire 04/11/2023 Medigene presents new data for MDG2011, the first TCR in a novel KRAS library, demonstrating capabil...